Aicuris Unveils Groundbreaking Pharmacokinetic Data for AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus
Aicuris presents promising pharmacokinetic data from the first-in-human clinical trial of AIC468, a novel antisense…
Aicuris presents promising pharmacokinetic data from the first-in-human clinical trial of AIC468, a novel antisense…